Crypto News Battery X Metals has expanded its advisory board with an automotive industry veteran as it accelerates commercialization of its lithium-ion battery rebalancing technology. The patent-pending system corrects cell imbalance to restore driving range without replacing entire electric-vehicle packs. The company says road tests lifted a heavily degraded commercial EV from roughly 40 km to 295 km of range, with the improvement largely holding after four months and more than 2,000 km of use. It is also building adapters for Tesla's Model 3 battery platform and pursuing UL certification. The firm estimates about 40 million electric and hybrid vehicles worldwide will exit battery warranties by 2031, opening a sizable aftermarket opportunity. Decentralized AI tokens rallied sharply after the U.S. administration restricted overseas access to a leading American AI model, a move reportedly triggered by Amazon chief executive Andy Jassy flagging a jailbreak vulnerability. The episode underscored how quickly Washington can control distribution of centralized AI systems, pushing investors toward censorship-resistant infrastructure. Bittensor (TAO) surged roughly 23.9% over 24 hours, while VVV climbed about 16% and Near Protocol (NEAR) added 6.2%. The blockchain-based AI narrative gained traction as traders bet that regulatory pressure on centralized providers favors distributed alternatives. Analysts framed the rotation as a structural signal rather than a one-off event, linking AI-security policy directly to demand for decentralized compute networks. A new study on regional finance detailed how shrinking bank-branch networks reshape local business ecosystems. Tracking 161 districts in South Korea between 2016 and 2024, researchers found that each additional branch in an area corresponded to about 29 more business launches and roughly 33 fewer closures in the same year. Domestic branch counts fell about 28%, from 7,702 in late 2012 to 5,513 in 2025, with non-capital metropolitan regions hit hardest. The report argued that physical branches operate as financial infrastructure for on-the-ground credit assessment, especially for small enterprises, and warned that accelerating digital finance could widen regional gaps without targeted policy support. In biotech, AstraZeneca secured FDA approval for TRUQAP (capivasertib) in combination with abiraterone and prednisone to treat PTEN-deficient metastatic prostate cancer. The clearance, backed by the Phase III CAPItello-281 trial, reduced the risk of radiographic disease progression or death by 19% and extended median progression-free survival to 33.2 months from 25.7 months. Prostate cancer ranks as the second most common cancer in men, with roughly 1.4 million new diagnoses annually and about 25% of high-risk patients carrying PTEN-deficient tumors. The FDA simultaneously approved a companion diagnostic to identify eligible patients, reinforcing an accelerating shift toward biomarker-driven precision medicine across oncology pipelines. Regulatory and on-chain developments dominated the crypto briefing. T. Rowe Price's actively managed crypto ETF won SEC approval on June 12, clearing a key hurdle for a NYSE Arca listing, with the structure designed to hold five to fifteen assets including Bitcoin, Ethereum, Solana and XRP. On-chain data showed Circle's USDC circulation contracted by about 700 million over seven days to 74.8 billion tokens, while a single whale wallet shifted roughly 135 million USDC into the DeFi lending protocol Aave. Prediction market Polymarket separately drew backlash after a settlement-correction clause liquidated about 3.8 million dollars across 1,838 accounts, raising fresh questions over outcome finality. Sentiment data captured a sharp divergence within the altcoin market despite broad extreme fear. OpenLedger (OPEN) traded near 379 won, up 4.70% on the day, as it topped exchange greed rankings alongside other AI-themed tokens. Bittensor (TAO) shared the top tier with a greed score of 88, while Akash Network (AKT) reached 85 and Worldcoin (WLD) registered 81. The clustering of artificial-intelligence projects at the most greedy end of the spectrum highlighted how the decentralized AI narrative concentrated speculative flows even as the wider market stayed defensive. Traders rotated into the theme while assets outside it lingered firmly in fear territory. Taken together, the week's events trace a single arc: capital is rotating toward narratives perceived as structurally resilient — decentralized AI, regulated crypto exposure and biomarker-driven assets — even as broad risk appetite collapses into a bear-market posture. COINOTAG's aggregate market data underscores the caution, with the Fear & Greed Index at 18, firmly in extreme fear, and Bitcoin dominance elevated at 70.5% as total crypto market capitalization sits near 1.83 trillion dollars. With Bitcoin holding around 64,000 dollars, the SEC's approval of a multi-asset crypto ETF and the surge in decentralized AI tokens suggest selective conviction beneath a defensive surface, where investors increasingly favor primary-source catalysts — official filings and verifiable on-chain flows — over momentum alone.
T. Rowe Price Crypto ETF Clears SEC as Bittensor Jumps 24%, USDC Supply Drops $700M
Crypto News Battery X Metals has expanded its advisory board with an automotive industry veteran as it accelerates commercialization of its lithium-ion battery rebalancing technology. The patent-pending system corrects cell imbalance to res
Crypto News Battery X Metals has expanded its advisory board with an automotive industry veteran as it accelerates commercialization of its lithium-ion battery rebalancing technology. The patent-pending system corrects cell imbalance to res
- The firm estimates about 40 million electric and hybrid vehicles worldwide will exit battery warranties by 2031, opening a sizable aftermarket opportunity.
- Bittensor (TAO) surged roughly 23.9% over 24 hours, while VVV climbed about 16% and Near Protocol (NEAR) added 6.2%.
- Domestic branch counts fell about 28%, from 7,702 in late 2012 to 5,513 in 2025, with non-capital metropolitan regions hit hardest.
- Prostate cancer ranks as the second most common cancer in men, with roughly 1.4 million new diagnoses annually and about 25% of high-risk patients carrying PTEN-deficient tumors.
- Prediction market Polymarket separately drew backlash after a settlement-correction clause liquidated about 3.8 million dollars across 1,838 accounts, raising fresh questions over outcome finality.
What people are saying
Hot takes
Loading takes…
Comments
Discussion · 0
Sign in to comment, like, and save articles.
Sign inLoading comments…
